tm
Seeing Is Believing
tm
Seeing Is Believing
with an average price target of $0.12. This is a potential upside of $0.12 (0%) from yesterday's end of day stock price of $0.
Sierra Oncology's activity chart (see below) currently has 25 price targets and 15 ratings on display.
Analysts average stock forecasts to be materialized ratio is 79.17% with an average time for these price targets to be met of 196.75 days.
Most recent stock forecast was given by JAY OLSON from OPPENHEIMER on 14-Apr-2022. First documented stock forecast 23-Oct-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-Apr-2022
$55
$0.01 (0.02%)
$45
3 years 10 months 2 days ago
(14-Apr-2022)
5/6 (83.33%)
$0.25 (0.46%)
442
Hold Since 10-Aug-2020
$39
$-15.99 (-29.08%)
$17
3 years 10 months 2 days ago
(14-Apr-2022)
2/3 (66.67%)
$-15.75 (-28.77%)
110
Hold Since 13-Apr-2022
$55
$0.01 (0.02%)
$51
3 years 10 months 3 days ago
(13-Apr-2022)
2/3 (66.67%)
$0.25 (0.46%)
102
Buy Since 27-Sep-2021
$39
$-15.99 (-29.08%)
$33
4 years 2 months 15 days ago
(01-Dec-2021)
3/3 (100%)
$15.72 (67.53%)
133
What is SRRA (Sierra Oncology) average time for price targets to be met?
Which analyst has the current highest performing score on SRRA (Sierra Oncology) with a proven track record?
Which analyst has the current lower performing score on SRRA (Sierra Oncology) with a proven track record?
Which analyst has the most public recommendations on SRRA (Sierra Oncology)?
Which analyst is the currently most bullish on SRRA (Sierra Oncology)?
Which analyst is the currently most reserved on SRRA (Sierra Oncology)?
